Stock Comparison

ASND vs VRTX

Ascendis Pharma AS and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ASND

Ascendis Pharma AS

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$16.14B

$123.94B

P/E (TTM)

28.1

28.5

Forward P/E

15.4

25.7

Price/Sales

18.6

9.9

Price/Book

28.7

6.1

EV/EBITDA

-20.0

23.2

Dividend Yield

—

Profitability

Net Margin

58.40%

35.40%

Operating Margin

-0.80%

38.97%

Return on Equity

33.30%

23.50%

Return on Assets

-0.60%

11.90%

Growth (YoY)

Revenue Growth

144.30%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

0.5

0.3

52-Week High

$277.18

$529.65

52-Week Low

$189.74

$376.62

Analyst Target

$309.46

$559.28

Compare ASND and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.